ArticleTechnology in cancer research & treatment
Predicting Mesothelioma Using Artificial Intelligence: A Scoping Review of Common Models and Applications.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Recent advances in artificial intelligence across interventional pulmonology: a narrative review.Journal of thoracic disease · 2026Review
- Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview.Thoracic cancer · 2026Review
- Review
- Application of AI in the identification of gastrointestinal stromal tumors: a comprehensive analysis based on pathological, radiological, and genetic variation features.Frontiers in genetics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IntroductionMesothelioma is a type of lung cancer caused by asbestos exposure, and early diagnosis is crucial for improving survival chances. Artificial intelligence offers a potential solution for the timely diagnosis and staging of the disease. This study aims to review the latest research conducted in artificial intelligence applications to predict mesothelioma.MethodsUntil April 24, 2023, PubMed, Scopus, and Web of Science databases were searched comprehensively for articles on artificial intelligence in mesothelioma management. The data was gathered using a standardized extraction form, and the findings were reported in figures and tables.ResultsOne hundred and seventy-three articles were identified from database searches, which were then reduced to 151 after eliminating duplicates. Finally, 19 articles were selected for inclusion in our study. The applications of artificial intelligence in these articles primarily focused on tumor diagnosis and classification (73.69%), followed by prevention and prognosis (21.05%) and tumor volumetric measurement of malignant pleural mesothelioma (5.26%). The most frequently used AI models include types of neural networks (NN), decision trees (DT), random forests (RF), logistic regression (LogR), Naïve Bayes (NB), and support vector machines (SVM). SVM, DT, and RF emerged as prominent models, achieving high accuracies ranging from 78.3% to 99.97%. Genetic algorithms, correlation-based algorithms, and Neural Networks were employed for risk factor identification and feature selection.ConclusionArtificial intelligence, particularly machine learning models such as neural networks, decision trees, support vector machines, and random forests, holds promise in predicting and managing mesothelioma, potentially enhancing early detection and improving patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.